PHARMEX CONSULTING LTD

Company number 09737525 ·

Active

Net assets, total assets & total liabilities 2016 – 2026

  • Total assets
  • Net assets
  • Total liabilities
-£500k £0 £500k £1m £1.5m £2m £2.5m 2016 2017 2018 2019 2020 2021 2023 2024 2025 2026 Total assets 2016: £176,785 Total assets 2017: £462,800 Total assets 2018: £640,569 Total assets 2019: £780,615 Total assets 2020: £838,200 Total assets 2021: £1,038,423 Total assets 2023: £1,523,293 Total assets 2024: £1,748,401 Total assets 2025: £2,035,410 Total assets 2026: £2,275,233 Total assets Net assets 2021: £982,180 Net assets 2023: £1,403,637 Net assets 2024: £1,647,951 Net assets 2025: £1,940,035 Net assets 2026: £2,196,534 Net assets Total liabilities 2016: -£53,586 Total liabilities 2017: -£72,279 Total liabilities 2018: -£55,713 Total liabilities 2019: -£53,014 Total liabilities 2020: -£31,661 Total liabilities 2021: -£56,243 Total liabilities 2023: -£114,404 Total liabilities 2024: -£100,450 Total liabilities 2025: -£108,908 Total liabilities 2026: -£89,332 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2025 – 2026

0 0 0 0 1 1 1 1 2 2025 2026 2025: 2 2026: 2

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 10 years

Latest accounts (2026-03-31): Audit exempt (accountant's report).

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2026-03-31 £2,275,233 -£89,332 £2,196,534 2
2025-03-31 £2,035,410 -£108,908 £1,940,035 2
2024-03-31 £1,748,401 -£100,450 £1,647,951
2023-03-31 £1,523,293 -£114,404 £1,403,637
2021-12-31 £1,038,423 -£56,243 £982,180
2020-12-31 £838,200 -£31,661
2019-12-31 £780,615 -£53,014
2018-12-31 £640,569 -£55,713
2017-12-31 £462,800 -£72,279
2016-12-31 £176,785 -£53,586

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.